Ausgabe 1/2010
Inhalt (32 Artikel)
Approaches and limitations of phosphatidylinositol-3-kinase pathway activation status as a predictive biomarker in the clinical development of targeted therapy
Christina M. Coughlin, Daniel S. Johnston, Andrew Strahs, Michael E. Burczynski, Sarah Bacus, Jason Hill, Jay M. Feingold, Charles Zacharchuk, Anna Berkenblit
Fertility drugs and the risk of breast cancer: a meta-analysis and review
Tony G. Zreik, Ali Mazloom, Yanli Chen, Marina Vannucci, Chelsea C. Pinnix, Stephanie Fulton, Mersiha Hadziahmetovic, Nadia Asmar, Adnan R. Munkarah, Chakib M. Ayoub, Ferial Shihadeh, Ghina Berjawi, Antoine Hannoun, Pierre Zalloua, Christine Wogan, Bouthaina Dabaja
Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109
Alexandra Hockla, Derek C. Radisky, Evette S. Radisky
UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs
Wei Jin, Yang Liu, Si-guang Xu, Wen-jin Yin, Jun-jie Li, Jin-ming Yang, Zhi-ming Shao
The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion
Eun-Sook Kim, Jae-Boon Jeong, Seonhoe Kim, Kyung-Min Lee, Eunyoung Ko, Dong-Young Noh, Ki-Tae Hwang, Ji Hee Ha, Chang Ho Lee, Sang Geon Kim, Aree Moon
17β-Estradiol enhances α5 integrin subunit gene expression through ERα–Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells
Diego Sisci, Emilia Middea, Catia Morelli, Marilena Lanzino, Saveria Aquila, Pietro Rizza, Stefania Catalano, Ivan Casaburi, Marcello Maggiolini, Sebastiano Andò
Synergistic activity of letrozole and sorafenib on breast cancer cells
Mara A. Bonelli, Claudia Fumarola, Roberta R. Alfieri, Silvia La Monica, Andrea Cavazzoni, Maricla Galetti, Rita Gatti, Silvana Belletti, Adrian L. Harris, Stephen B. Fox, Dean B. Evans, Mitch Dowsett, Lesley-Ann Martin, Alberto Bottini, Daniele Generali, Pier Giorgio Petronini
The role of microRNA-128a in regulating TGFbeta signaling in letrozole-resistant breast cancer cells
Selma Masri, Zheng Liu, Sheryl Phung, Emily Wang, Yate-Ching Yuan, Shiuan Chen
New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines
Christelle Colin, Stéphane Salamone, Isabelle Grillier-Vuissoz, Michel Boisbrun, Sandra Kuntz, Julie Lecomte, Yves Chapleur, Stéphane Flament
Beyond bisphosphonates: photodynamic therapy structurally augments metastatically involved vertebrae and destroys tumor tissue
Emily Won, Lisa Wise-Milestone, Margarete K. Akens, Shane Burch, Albert J. M. Yee, Brian C. Wilson, Cari M. Whyne
Anti-HER2 immunoliposomes for selective delivery of electron paramagnetic resonance imaging probes to HER2-overexpressing breast tumor cells
Scott R. Burks, Luciana F. Macedo, Eugene D. Barth, Katherine H. Tkaczuk, Stuart S. Martin, Gerald M. Rosen, Howard J. Halpern, Angela M. Brodie, Joseph P. Y. Kao
Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
Jens Huober, Gunter von Minckwitz, Carsten Denkert, Hans Tesch, Erich Weiss, Dirk Michael Zahm, Antje Belau, Fariba Khandan, Maik Hauschild, Christoph Thomssen, Bernhard Högel, Silvia Darb-Esfahani, Keyur Mehta, Sibylle Loibl
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons
Umberto Veronesi, Roberto Orecchia, Alberto Luini, Viviana Galimberti, Stefano Zurrida, Mattia Intra, Paolo Veronesi, Paolo Arnone, Maria Cristina Leonardi, Mario Ciocca, Roberta Lazzari, Pietro Caldarella, Nicole Rotmensz, Claudia Sangalli, Daniele Sances, Patrick Maisonneuve
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane Study
Robert E. Coleman, Linda M. Banks, Samia I. Girgis, Eduard Vrdoljak, John Fox, Simon J. Cawthorn, Ashraf Patel, Judith M. Bliss, R. Charles Coombes, Lucy S. Kilburn
Multimodal exercise improves quality of life of women being treated for breast cancer, but at what cost? Randomized trial with economic evaluation
Terry P. Haines, Patricia Sinnamon, Neil G. Wetzig, Margot Lehman, Euan Walpole, Tony Pratt, Amanda Smith
Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy
Mark Clemons, Anil A. Joy, Radhi Abdulnabi, Mauricio Kotliar, Jodi Lynch, Johan P. Jordaan, Neill Iscoe, Karen Gelmon
The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer
Zsolt Gabos, John Thoms, Sunita Ghosh, John Hanson, Jean Deschênes, Siham Sabri, Bassam Abdulkarim
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers
Susan M. Domchek, Tara M. Friebel, Judy E. Garber, Claudine Isaacs, Ellen Matloff, Rosalind Eeles, D. Gareth Evans, Wendy Rubinstein, Christian F. Singer, Stephen Rubin, Henry T. Lynch, Mary B. Daly, Jeffrey Weitzel, Patricia A. Ganz, Gabriella Pichert, Olufunmilayo I. Olopade, Gail Tomlinson, Nadine Tung, Joanne L. Blum, Fergus Couch, Timothy R. Rebbeck
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors
H. Irene Su, Mary D. Sammel, Erin Springer, Ellen W. Freeman, Angela DeMichele, Jun J. Mao
Are there racial/ethnic disparities among women younger than 40 undergoing mammography?
Julie M. Kapp, Rod Walker, Sebastien Haneuse, Diana S. M. Buist, Bonnie C. Yankaskas
The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis
Lei Yao, Fang Fang, Yang Zhong, Long Yu
XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects
Li-Xin Qiu, Lei Yao, Jian Zhang, Xiao-Dong Zhu, Xin-Min Zhao, Kai Xue, Chen Mao, Bo Chen, Ping Zhan, Hui Yuan, Xi-Chun Hu
Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population
Jie Liang, Peizhan Chen, Zhibin Hu, Hao Shen, Furu Wang, Lu Chen, Mian Li, Jinhai Tang, Hui Wang, Hongbing Shen
Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects
Wenquan Niu, Yue Qi, Pingjin Gao, Dingliang Zhu
Four new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations: clinical, pathological, and family characteristics
Monica Zuradelli, Bernard Peissel, Siranoush Manoukian, Daniela Zaffaroni, Monica Barile, Valeria Pensotti, Ugo Cavallari, Giovanna Masci, Frederique Mariette, Anne Caroline Benski, Armando Santoro, Paolo Radice
Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer
Thomas v. O. Hansen, Lars Jønson, Anders Albrechtsen, Ane Y. Steffensen, Eva Bergsten, Torben Myrhøj, Bent Ejlertsen, Finn C. Nielsen
TMS, a chemically modified herbal derivative of Resveratrol, induces cell death by targeting Bax
Sarah E. Aiyar, Hoyong Park, Paulomi B. Aldo, Gil Mor, John J. Gildea, Aaron L. Miller, E. Brad Thompson, J. David Castle, Sanghee Kim, Richard J. Santen
Angiosarcoma following MammoSite® partial breast irradiation
Samuel Andrews, Rebecca Wilcoxon, Jo Benda, Geraldine Jacobson
Mutation and association analysis of GEN1 in breast cancer susceptibility
Clare Turnbull, Sarah Hines, Anthony Renwick, Deborah Hughes, David Pernet, Anna Elliott, Sheila Seal, Margaret Warren-Perry, D. Gareth Evans, Diana Eccles, Michael R. Stratton, Nazneen Rahman
Combined UGT1A1 and UGT1A6 genotypes together with a stressful life event increase breast cancer risk
Christina Justenhoven, Stefan Winter, Thomas Dünnebier, Ute Hamann, Christian Baisch, Sylvia Rabstein, Anne Spickenheuer, Volker Harth, Beate Pesch, Thomas Brüning, Yon-Dschun Ko, Hiltrud Brauch
Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis
Konstantinos P. Economopoulos, Theodoros N. Sergentanis
Comments on: Sluiter MD and van Rensburg EJ, Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation
Jesús del Valle, Lídia Feliubadaló, Conxi Lázaro